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Nonsyndromic or isolated cleft lip with or without cleft palate (CL/P) occurs in wide geographic distribution with an
average birth prevalence of 1/700. We used direct sequencing as an approach to study candidate genes for CL/P. We
report here the results of sequencing on 20 candidate genes for clefts in 184 cases with CL/P selected with an emphasis
on severity and positive family history. Genes were selected based on expression patterns, animal models, and/or role
in known human clefting syndromes. For seven genes with identified coding mutations that are potentially etiologic,
we performed linkage disequilibrium studies as well in 501 family triads (affected child/mother/father). The recently
reported MSX1 P147Q mutation was also studied in an additional 1,098 cleft cases. Selected missense mutations were
screened in 1,064 controls from unrelated individuals on the Centre d’E´tude du Polymorphisme Humain (CEPH)
diversity cell line panel. Our aggregate data suggest that point mutations in these candidate genes are likely to
contribute to 6% of isolated clefts, particularly those with more severe phenotypes (bilateral cleft of the lip with cleft
palate). Additional cases, possibly due to microdeletions or isodisomy, were also detected and may contribute to clefts
as well. Sequence analysis alone suggests that point mutations in FOXE1, GLI2, JAG2, LHX8, MSX1, MSX2, SATB2, SKI,
SPRY2, and TBX10 may be rare causes of isolated cleft lip with or without cleft palate, and the linkage disequilibrium
data support a larger, as yet unspecified, role for variants in or near MSX2, JAG2, and SKI. This study also illustrates the
need to test large numbers of controls to distinguish rare polymorphic variants and prioritize functional studies for
rare point mutations.
Citation: Vieira AR, Avila JR, Daack-Hirsch S, Dragan E, Fe´lix TM, et al. (2005) Medical sequencing of candidate genes for nonsyndromic cleft lip and palate. PLoS Genet 1(6): e64.
Introduction
Nonsyndromic or isolated cleft lip with or without palate
(CL/P) occurs in wide geographic distribution with an average
birth prevalence of 1/700 [1]. CL/P is a complex trait
determined by multiple, interacting loci, with additional
environmental covariates. Recent work suggests that three to
14 interacting loci provide a good model for genetic effects in
CL/P [2].
Studying candidate genes for CL/P selected from animal
models and expression patterns is a common strategy [3]. To
identify gene(s) involved in CL/P, investigators have used both
association and linkage approaches to evaluate genetic
contributions. To detect the very small gene effects on CL/P
by linkage or linkage disequilibrium strategies, sample sizes
need to be large and there needs to be either a common
variant in association (for linkage disequilibrium) or a
substantial degree of single locus contributions (for linkage).
We used direct sequencing as an alternative approach to study
candidate genes for CL/P hoping to identify genes with modest
effects on the disease. The results of the direct sequencing of
MSX1 [4,5] suggest that point mutations in this gene underlie
approximately 2% of CL/P cases. We report here the results of
sequencing 20 additional candidate genes for clefts. For seven
genes with identiﬁed coding mutations that are potentially
etiologic, we performed linkage disequilibrium studies as well.
For theMSX1 P147Qmutation reported by Suzuki et al. [5], we
investigated an additional 1,098 cleft cases.
Results
One hundred and forty-nine exons (representing 77,527
nucleotides of DNA sequencing), including exon–intron
boundaries and untranslated regions, of 20 genes were
screened for mutations in the Iowa and Philippines cleft
populations. Table 2 summarizes the number of variants and
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putative mutations observed. Of the 256 variants seen, 16
missense mutations in nine genes seemed to be of potential
etiologic importance. All 16 missense mutations were
observed in a single cleft lip and palate case, with the
exception of the SPRY2 D20A and TBX10 R354Q mutations
that were seen in two and three cases respectively. None were
seen in the 186 matched controls (Table 3). These mutation
sites are not highly conserved across species with the
exception of the SPRY2 and GLI2 mutations. Both SPRY2
mutation sites as well as three GLI2 mutation sites are
conserved from Xenopus to human (Figure 1; complete data
available at http://genetics.uiowa.edu/publication/html). The
JAG2 and the TBX10 R354Q mutation sites are not conserved
in other species orthologs available for study. The sequence
surrounding the JAG2 A657H mutation site is likely a
calcium-binding EGF-like domain, which is present in a large
number of membrane-bound and extracellular proteins. Also,
the SPRY2 K68N mutation site is in the sprouty domain and
inhibits the Ras/mitogen-activated protein kinase (MAPK)
cascade, a pathway crucial for developmental processes
initiated by activation of various receptor tyrosine kinases.
All mutations were predicted to be benign by PolyPhen
(http://www.bork.embl-heidelberg.de/PolyPhen/) with the ex-
ception of the JAG2 M597I and SPRY2 D20A that were
‘‘possibly damaging’’ and GLI2 S1213Y that was ‘‘probably
damaging’’ (Table 3). However, with the exception of the
LHX8 E221A, GLI2 R426Q, and GLI2 S1213Y mutations, all
missense mutations appear to potentially disrupt splicing by
either creating or inactivating exonic splicing enhancer
sequences (complete information is available as supplemental
material at http://genetics.uiowa.edu/publications.html/).
None of the mutations identiﬁed in this study appear to
disrupt possible exonic splicing silencer sequences.
The SATB2 T190A mutation was not found in the panel of
1064 CEPH controls as well. We also tested the LHX8 E221A,
SKI A388V, SPRY2 D20A, and TBX10 R354Q mutations in the
panel of 1064 CEPH controls after not seeing it in 200
population matched controls. We found the LHX8 E221A
mutation in 17 samples, the SKI A388V mutation in nine
samples, the SPRY2 D20A mutation in 60 samples, and the
TBX10 R354Q mutation in six samples. (A complete list is
Table 1. Candidate Genes Studied
Gene Map Location KOa L/LDb CHc Other Reason to Be Selected as Candidate Reference
FOXE1 9q22 þ þ  — [9,28,47]
GLI2 2q14    Mutations in GLI2 cause holoprosencephaly-like features with cleft lip and palate [11]
ISGF3G 14q11.2 NA   Similar to IRF6 —
JAG2 14q32 þ   — [48]
LHX8 1p31 þ   — [49]
MSX2 5q34-q35    Similar to MSX1 —
NAT1 8p23.1–21.3 NA þ  Correlates with glucocorticoid-induced cleft palate in mice and is involved in
smoking detoxification
[50,51]
OSR2 8q22.2 þ þ  — [28,52]
P63 3q27-q29    Mutations cause a syndromic form of clefting (ectrodactyly, ectodermal dysplasia,
and orofacial clefts)
[53]
PAX9 14q12-q13 þ   — [54]
SATB2 2q32-q33 NA þ þ — [28,46]
SKI 1p36.3 þ þ þ — [44,45]
SPRY1 4q28.1 NA   Sprouty expression is induced by the fibroblast growth factor receptor (FGFR)
pathway. Loss-of-function mutations in FGFR1 cause a syndromic form of clefting
(Kallmann syndrome)
[35,55]
SPRY2 13q22.2 NA   See SPRY1 [35,55]
TBX1 22q11.21 þ  þ Mutations cause a syndromic form of clefting (DiGeorge syndrome) [56,57]
TBX10 11q13.1 NA   Ectopically expressed in Dancer cleft lip and palate mutant mice [58]
TGFA 2p13    — [28]
TGFB1 19q13.2  þ  — [28]
TGFB3 14q24.3 þ þ  — [43,59,60]
TGFBR1 9q22  þ  — [28]
aA plus sign (þ) indicates a knockout mouse with clefts; a negative sign () indicates a knockout mouse without clefts.
bA plus sign (þ) indicates indicates evidence of linkage/linkage disequilibrium; a negative sign () indicates no evidence of linkage/linkage disequilibrium.
cA plus sign (þ) indicates evidence of chromosome rearrangements; a negative sign () indicates no evidence of chromosome rearrangements.
NA, not available.
DOI: 10.1371/journal.pgen.0010064.t001
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Synopsis
Nonsyndromic or isolated cleft lip with or without cleft palate (CL/P)
is a birth defect with wide geographic distribution, occurring with
an average frequency of 1/700 live births. Treatment can be
provided, but it will involve medical, surgical, dental, and
psychological personnel. Several different genes have been impli-
cated in different cases. Here the researchers report the results of
sequencing 20 different genes in 184 CL/P cases selected with an
emphasis on more severe cases and cases with a positive family
history for CL/P. Genes were selected based on previous work done
by others and by the researchers’ group. The authors’ results
suggest that point mutations in these candidate genes are likely to
contribute to about 5% of CL/P, and particularly those with more
severe phenotypes (bilateral cleft of the lip with cleft palate). This
study also illustrates the need to test large numbers of controls to
distinguish rare polymorphic variants and allow investigators to
focus functional studies on the rare point mutations that seem to be
disease-causing, so that researchers might better understand the
mechanisms that play a role in CL/P.
available at our Web site: http://genetics.uiowa.edu/
publications.html).
The MSX1 P147Q mutation was not found in any of 1,671
controls but was found in two Filipino cleft families from a
panel of 1,468 cleft cases from the Philippines, which
indicates a frequency of 0.14%. The ﬁrst family has no family
history for clefting and the variant segregates from the
unaffected mother. The second family has four affected with
clefts. The variant was found in two cousins and segregates
from the unaffected grandmother to her unaffected son and
daughter of a sibship of nine. A ﬁrst cousin of the proband is
affected but does not carry the variant. The last affected, a
third cousin once removed, also has a cleft but does not carry
the variant (Figure 2).
The LHX8 and SATB2 mutations were originally seen in
single cases from the Philippines. For SATB2 T190A, the
variant was transmitted from the unaffected mother. The
LHX8 E221A mutation was also transmitted from the
unaffected mother and is present in one affected and one
unaffected person but was absent in two unaffected siblings
from a sibship of eight brothers and sisters (Figure 3). Both
mutation sites are conserved between human and mouse (see
Appendix at http://genetics.uiowa.edu/publications.html/).
The SKI A388V mutation was seen in a case from Iowa. The
mutation was transmitted from the mother and the mutation
site is conserved between humans and species of ﬁsh and frog.
Two cases from Iowa presented with the SPRY2 D20A
mutation. Of these, one had parental DNA samples available
and the mutation segregated from the unaffected mother.
Three cleft individuals from Iowa presented the TBX10
R354Q mutation. In the two cases with parent samples
available, one received the mutated allele from the mother
and the other from the father (both unaffected).
Two additional interesting observations were made. An
Iowa case presented with isolated cleft lip with cleft palate,
and no family history of clefts or any features of DiGeorge
syndrome was found to be homozygous for an intronic
variant in the TBX1 gene (189 nucleotides into intron 8). This
variant was not present in 186 matched controls. We tested
this case for the presence of two copies of the ubiquitin
fusion degradation gene (UFD1L), using an assay for DiGeorge
or 22q syndrome [6], and the results were normal. Parental
samples are not available to further study this case, nor is
there enough DNA available to conﬁrm a possible deletion by
Southern blot analysis. The ﬁnding of a single rare
homozygote variant suggests the possibility of a micro-
deletion or segmental isodisomy of this region. We tested
four microsatellite markers (D22S420, D22S1685, D22S683,
and D22S445) on both proband and mother samples. The
mother presents distinct genotypes from the proband for
D22S420 and D22S683 markers, however this ﬁnding does not
exclude a segmental maternal isodisomy because the interval
between these two markers, which contains TBX1, is 32 cM
(data not shown).
The second observation involved four Filipino cases that
presented a missense mutation in the last SKI amino acid
(P728L). This mutation was not found in 186 matched
controls. One case appears to have a de novo SKI P728L
mutation. This case presented with an isolated right cleft lip
and cleft palate and positive family history for clefts. Neither
parent had this variant and their biological relationship to
the case was conﬁrmed after testing twenty polymorphic
markers. Of the other three cases, one had a positive family
history for clefts. For this case, we tested the parents, the
paternal grandparents and three siblings out of a 15 sibship
progeny. One of the tested siblings is affected with a right
cleft lip and cleft palate associated with microcephaly. The
SKI P728L variant segregated from the unaffected grand-
Table 2. Summary of Variants Found by Direct Sequence
Genes Location Frequency Total
Coding Variants Non-Coding Variants .5% ,5%
Syn Non-syn PE Intron 59UTR 39UTR
FOXE1 10 2 A207V, D285V — — — 3 9 12
GLI2 3 10 R46H, R426Q, G778D, S1213Y — — — 5 8 13
ISGF3G 4 — — 6 — 3 3 10 13
JAG2 7 10 M597I, A657H 11 1 10 7 32 39
LHX8 1 1 E221A 2 — 1 2 3 5
MSX2 1 2 S63C 1 — — 2 2 4
NAT1 3 7 — — — — 7 3 10
OSR2 — — — — — — — — 0
P63 — — — 17 2 — 9 10 19
PAX9 1 1 — — — — 2 — 2
SATB2 — 1 T190A 3 — — 1 3 4
SKI 5 4 A388V 6 — 8 6 17 23
SPRY1 — — — — — 3 3 — 3
SPRY2 — 3 D20A, K68N — 4 — 2 5 7
TBX1 5 1 — 7 8 11 14 18 32
TBX10 — 4 R354Q 15 — 3 13 9 22
TGFA 2 — — 13 2 16 10 23 33
TGFB1 — 2 — 2 2 — 1 5 6
TGFB3 1 — — 1 4 — 3 3 6
TGFBR1 1 1 — 1 — — 1 2 3
Non-syn, non-synonymous; PE, potentially etiologic; Syn, synonymous.
DOI: 10.1371/journal.pgen.0010064.t002
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father to the unaffected father. Of the three siblings tested,
the two unaffected siblings had the variant, but the affected
sibling did not. Based on this family, we concluded that this
SKI P728L variant is probably not an etiologic mutation and
included it in the column of non-synonymous coding variants
in Table 2.
Linkage disequilibrium studies were performed for the
genes GLI2, JAG2, MSX2, SATB2, SKI, SPRY2, and TBX10 in
which likely etiologic missense mutations had been observed
(complete information is available as supplemental material
at http://genetics.uiowa.edu/publications.html/; results for
FOXE1 were previously reported in Marazita et al. [7]). No
single nucleotide polymorphism tested showed evidence for
deviation from Hardy-Weinberg equilibrium in either the
affected or unaffected individuals (data not shown). The
haplotype analysis using the HBAT function of FBAT (http://
www.biostat.harvard.edu/;fbat/fbat.htm) demonstrated bor-
derline associations between MSX2 in both Filipino (p ¼
0.001) and Iowa (p¼0.008) populations, between JAG2 and the
Filipinos (p ¼ 0.004), and between both SATB2 (p ¼ 0.03) and
TBX10 (p¼ 0.04) and the Iowa population. However, when we
combined the MSX2 haplotype data for both Filipino and
Iowa populations, the association was weaker (p ¼ 0.09). We
also observed an association between CL/P and snp2
(rs2843159) in SKI (p ¼ 0.000004) in the Filipino population.
This association between CL/P and SKI in Filipinos was also
suggested by the haplotype analysis (p ¼ 0.0002). In addition,
the same SKI snp2 marker showed association with cleft lip
only in the South American clefting population from the
Latin American Collaborative Study of Congenital Malfor-
mations (ECLAMC) (p ¼ 0.004).
Discussion
Point mutations in the candidate genes FOXE1, GLI2,
MSX2, SKI, SATB2, and SPRY2 appear in aggregate to
contribute to as much as 6% of isolated cleft lip and palate
cases, enriched for cases with bilateral cleft of the lip with
cleft palate and a positive family history. The mutations
found in this study are conserved in other mammals, may
disrupt exonic splicing enhancer sequences, and were not
found in between 400 to 2,000 control chromosomes. The
JAG2 M597I and A657H mutations, although they appear to
disrupt exonic splicing enhancer sequences and possibly
damage the JAG2 protein, according to the PolyPhen
prediction, are not conserved in other species and may be
rare polymorphic sites.
Testing a larger number of control samples proved to be a
useful way to differentiate rare polymorphisms from etiologic
mutations. The LHX8 E221A, SATB2 T190A, SKI A388V,
SPRY2 D20A, and TBX10 R354Q variants initially were not
observed in approximately 200 matched controls. This
number of controls is commonly used to assume that if a
variant is not present, it is likely causal despite models that
have shown that a larger number of controls is useful in
eliminating rare variants [8]. However, when we tested these
variants in the extended set of 1,064 controls, we found the
LHX8 E221A variant in 17 individuals, the SKI A388V
mutation in nine, the SPRY2 D20A mutation in 60 individ-
uals, and the TBX10 R354Q in six individuals. Although the
presence of the amino acid changes in unaffected controls
does not exclude them from playing a role in CL/P, it does
place them in a lower priority group for additional functional
Table 3. Potential Mutations Found in the Present Study
Population (Number of Affected Individuals) Gene Amino Acid Change PolyPhen Prediction Phenotype FH Parents’ Genotypes
Clefts Othera Father Mother
Philippines (1/91) FOXE1 A207V Benign BL CL/P — Yes 207AV 207AA
Iowa (1/93) FOXE1 D285V Benign BL CL/P — Yes 285DD 285DV
Iowa (1/93) GLI2 R46H Benign R CL/P — No 46RR 46RH
Philippines (1/91) GLI2 R426Q Benign BL CL/P 1 Yes NA NA
Iowa (1/93) GLI2 G778D Benign R CL/P — No NA NA
Philippines (1/91) GLI2 S1213Y Probably damaging BL CL/P — Yes NA NA
Philippines (1/91) LHX8 E221Ab Benign BL CL/P — Yes 221EE 221EA
Iowa (1/93) JAG2 M597I Possibly damaging BL CL/P — No NA NA
Philippines (1/91) JAG2 A657H Benign BL CL/P — Yes 657AA NA
Iowa (1/93) MSX2 S63C Benign L CL/P 2 No NA NA
Philippines (1/91) SATB2 T190Ac Benign BL CL/P — No 190TT 190TA
Iowa (1/93) SKI A388Vb Benign L CL/P — No 388AA 388AV
Iowa (2/93) SPRY2 D20A Possibly damaging R CL/P — Yes NA NA
L CL/P — No 20DD 20DA
Iowa (1/93) SPRY2 K68N Benign L CL/P — No NA NA
Iowa (3/93) TBX10 R354Qb Benign NA NA NA NA NA
L CL/P — Yes 354RR 354RQ
Unknown CL/P 3 No 354RQ 354RR
Philippines (2/1098) MSX1 P147Q Benign R CL/P — Yes 147PQ 147PP
BL CL/P 4 No 147PP 147PQ
The mutations in this table were not found in 186 matched controls. None of the cases presented an affected parent.
a1 indicates polydactyly; 2 indicates epicanthal folds; 3 indicates cafe´ au lait spots; 4 indicates hypertelorism.
bMutations not found in 186 controls but disclosed when an extended control set of 1,064 samples were studied.
cMutations not found in the extended control set of 1,064 samples.
BL CL/P, bilateral cleft lip with cleft palate; FH, family history for clefts; L CL/P, unilateral left cleft lip with cleft palate; NA, information not available, sample not available, or sequencing failed; R CL/P, unilateral right cleft lip with cleft palate.
DOI: 10.1371/journal.pgen.0010064.t003
PLoS Genetics | www.plosgenetics.org December 2005 | Volume 1 | Issue 6 | e640654
Direct Sequencing of CL/P Genes
analysis and makes them difﬁcult to use in any applied
genetic counseling setting as they may be, at best, modiﬁers
with low penetrance contributory alleles.
Some variants, such as the SKI A388V mutation, which is
conserved back to Xenopus and Tilapia but is found in
controls, demonstrate that species conservation alone maybe
not enough to argue for an etiologic role of a given variant.
Our study illustrates the difﬁculties of deﬁning as causal a
mutation rarely seen in the population. Many of the missense
mutations found in the cases studied were seen only when we
extended our screen to a larger control group comprised of
samples from ethnically diverse groups from almost all parts
of the world. In addition, none of the mutations segregated
from an affected parent. Incomplete penetrance is likely the
explanation for the mutations that may be causal as has been
clearly shown for other genes that contribute to clefting such
as MSX1 [9] and FGFR1 [10] mutations. It is likely that we
found these mutations only because we tested cases more
likely to present a stronger genetic contribution (cases with
positive family history and bilateral cleft of the lip with cleft
palate). Mutations like the MSX1 P147Q and others that
appear to show incomplete penetrance are comparable to
autosomal dominant disorders resulting from mutations in
SCN5A [11], IRF6 [12], or NKX2.5 [13].
TheMSX1 P147Q mutation was seen in two cleft cases from
the Philippines, but in none of the over 1,600 controls. It
appears that this speciﬁc mutation underlies approximately
0.15% cases of apparent isolated CL/P. As shown previously
this variant results in variable expression and decreased
penetrance that make prospective studies of its phenotypic
outcome necessary before accurate genetic counseling risk
can be measured [5].
Rigorous demonstration that a mutation disrupts a genuine
exonic splicing enhancer requires that the sequence auton-
omously promote splicing and that enhancement be absent in
the mutant. An advantage of the score matrix approach [14] is
that it allows direct testing of predicted effects on individual
putative enhancer sites, rather than having to characterize
exonic splicing enhancers by testing multiple random
Figure 1. Protein Comparisons of the Available Gene Orthologs for GLI2 S1213Y and SPRY2 D20A
GLI2 S1213Y (A) and SPRY2 D20A (B): Green bars indicate degree of conservation in each site. Amino acids in red indicate the mutation sites. All
mutation comparisons are available as supplemental material at http://genetics.uiowa.edu/publications.html.
DOI: 10.1371/journal.pgen.0010064.g001
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mutations and/or deletions along an exon. All 15 mutations
on Table S2 appear to inactivate and/or create a predicted
exonic splicing enhancer of at least one of the four serine/
arginine-rich (SR) proteins. However, the presence of a high-
score motif in a sequence does not necessarily identify that
sequence as an exonic splicing enhancer in its native context.
In TBX1, we found one rare intronic variant in homozygous
form in an Iowa cleft case, which could indicate that clefts
arise from recessive functional intronic mutations in TBX1, or
microdeletions that cannot be visualized by direct sequenc-
ing. This case does not have a 22q deletion involving the
UFD1L gene. Detecting this rare homozygote in the absence of
this variant in any other of the 400 people tested suggests
these individuals may be identical by descent at this locus and
gene. This variant itself, or others in linkage disequilibrium in
TBX1, might be a hypomorphic allele whose joint presence
results in enough change in gene expression or function to
trigger a phenotype. Therefore, other alleles in regulatory
regions of TBX1 should be a priority for identiﬁcation.
Previous work from our group has screened FGFR1, IRF6,
MSX1, TGFA, and TGFB3 for mutations on cleft cases. Point
mutations in MSX1 appear to contribute approximately to
2% of all CL/P cases [4]. FGFR1 point mutations also appear
to contribute to CL/P. In addition, FGFR1 loss-of-function
mutations can cause forms of Kallmann syndrome that mimic
isolated CL/P at birth and during childhood. Mutations in
IRF6, which cause the syndromic forms of clefts, the Van der
Woude and popliteal pterygium syndromes [12], were not
found in the same collection of cleft cases as the present
study, although rare non-coding variants in conserved
regions were disclosed. However, IRF6 is strongly associated
with CL/P, and it is likely a genetic modiﬁer for clefts [15,16].
Previously for TGFA, ﬁve variants in conserved non-coding
segments were found in individual cases but not seen in 278
controls [17]. In the present study we found another nine
non-coding rare variants in single individuals, but we did not
ﬁnd the original ﬁve reported rare variants or any coding
mutation that could be etiologic. If these variants are disease-
causing mutations, they could explain, not only the conﬂict-
ing results from association studies of isolated orofacial clefts
and TGFA variants [18], but also the linkage studies that
suggest a cleft susceptibility loci in 2p13, the TGFA locus [7].
For TGFB3, we previously reported one missense mutation
(K130R) in a cleft palate–only case not seen in 350 controls
[19]. We did not ﬁnd this or any other mutations in TGFB3 in
our current study population.
Loss-of-function mutations in GLI2 are associated with
pituitary anomalies and holoprosencephaly-like features [20].
In this report, the three pedigrees segregating GLI2 loss-of-
function mutations with complete clinical information
presented orofacial clefts and polydactyly. We found four
missense mutations in GLI2 in highly conserved amino acids.
One of the cases also presented with polydactyly (Table 3).
We performed linkage disequilibrium studies in the genes
that we found potentially disease-causing missense mutations.
We found association between a marker (rs2843159) and a
haplotype in SKI in the Filipino population. This association
was also found in an independent population dataset from
South America. The SKI locus, 1p36.3, was previously
suggested as a cleft susceptibility loci in Caucasians [21,22].
Ski null mice present with clefts involving the lip [22], and the
association we found appears to be stronger when cases with
the involvement of the lip are included.
The possible trend for an association between clefts with a
palate phenotype and SATB2 are in agreement with the
cytogenetic evidence. Deletions and balanced translocations
point to the existence of a locus on 2q32-q33, for which
haploinsufﬁciency results in isolated cleft palate. A mutation
analysis of SATB2 (located at 2q32-q33) in 70 unrelated
patients with isolated cleft palate only did not reveal any
coding region variants [23]. However, a meta-analysis of 13
genome scans for clefts indicated 2q32-q35 as a clefting
susceptibility locus [7]. We studied 184 cleft lip and palate
cases and found one missense mutation in SATB2 (T190A)
that was not seen in approximately 1,200 controls. Based on
the linkage disequilibrium and mutation analysis results of
our study, we believe a regulatory element outside SATB2
coding regions may be implicated in clefting.
Figure 2. Family Pedigree of the Filipino Family Segregating the MSX1
P147Q Mutation
PP (proline–proline) indicates the wild-type genotype. PQ (proline–
glutamine) indicates the genotype of the individuals carrying the
mutation.
DOI: 10.1371/journal.pgen.0010064.g002
Figure 3. Family Pedigree of the Filipino Proband with the LHX8 E221A
Mutation
The segregation pattern of the mutation is not consistent with a simple
Mendelian model for the disease.
EE (glutamic acid–glutamic acid) indicates the wild-type genotype. EA
(glutamic acid–alanine) indicates the genotype of the individuals
carrying the mutation.
DOI: 10.1371/journal.pgen.0010064.g003
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In summary, point mutations in six of the 20 candidate
genes selected from expression, animal, and human data may
to contribute to about 5% of isolated clefts, more likely those
with more-severe phenotypes and/or a positive family history.
Etiologic variants in regulatory elements of SKI, JAG2, and
MSX2 may contribute to isolated clefts as well. Predictions by
ESEﬁnder (http://rulai.cshl.edu/tools/ESE/) and PolyPhen re-
garding the function of the missense mutations found in this
study, as well as exonic splicing enhancement and protein
damaging, are challenging to interpret.
A major challenge in these studies was the frequent absence
of a cleft phenotype in near relatives of an affected proband
with a cleft and a rare missense mutation. In some cases these
variants may not be etiologic, but in others, reduced
penetrance for the cleft may be an active force as has been
seen commonly in clefts [9,10] and other birth defects such as
congenital hearth disease. Similarly these mutations may only
be modiﬁers of the phenotype.
Cases due to microdeletions or isodisomy may contribute
to clefts as well. This study illustrates the validity of testing
greater numbers of controls to determine rare polymorphic
variants and prioritize functional studies for rare point
mutations. Given other recent data on the roles of FGFR1,
IRF6, and MSX1 in isolated CL/P, one can begin to consider
sequencing of a panel of high-probability candidate genes for
genetic counseling indication. Although issues of penetrance
and even etiology for any given mutation are not yet resolved,
progress in this direction is now measurable.
Materials and Methods
Two collections of CL/P cases, 91 from the Philippines and 93 from
Iowa, United States, were used to search for mutations in 20
candidate genes (Table 1). We selected the more-severe cases from
those available to us, and the sequenced samples were enriched by
bilateral cleft lip and palate cases with a positive family history for
clefts (39/91 from the Philippines and 16/93 from Iowa). Two cases
were later found to have associated features—one with Stickler
syndrome in which family history was initially not available, and a
second with polydactyly. Cases from the Philippines were studied
under the auspices of Operation Smile International [24]. Patients
were seen and examined by a board certiﬁed clinical geneticist (JCM
or colleagues; see Acknowledgments) at one of four sites within the
Philippines (Cavite, Kalibo, Cebu, and Negros). Iowa cases were
collected through the Iowa Birth Defects Registry [25]. Signed
consents were obtained from all participants before a blood sample
was obtained. DNA was extracted according to published protocols.
For each of the 20 candidate genes, all exons and 59 and 39
untranslated regions were sequenced in both directions. Primer
sequences and PCR conditions are available on our Web site (http://
genetics.uiowa.edu/publications.html). Primers for FOXE1, GLI2,
MSX2, OSR2, and TGFBR1 were obtained from the literature
[20,26–29]. Cycle sequencing was performed in a 20-ll reaction using
4 ll of Applied Biosystems Big Dye Terminator sequencing reagent, 1
ll of 5 lM sequencing primer, 1 ll of DMSO, 4 ll of 2.53Buffer, and
2.5 ng/100 base pair of DNA template. Following a denaturation step
at 96 8C for 30 s, reactions were cycle sequenced at 96 8C for 10 s, 50
8C for 5 s, and 60 8C for 4 min for 40 cycles. Cleanup was performed
using standard protocols. Samples were resuspended in 40 to 100 ll
of ddH2O, and 2.5 ll were then injected on an Applied Biosystems
3700 sequencer. The Applied Biosystems sequence software (version
2.1.2) was used for lane tracking and ﬁrst pass base calling.
Chromatograms were transferred to a Unix workstation, base called
with PHRED (version 0.961028), assembled with PHRAP (version
0.960731), scanned by POLYPHRED (version 0.970312), and the
results viewed with CONSED (version 4.0) [30]. When the results
indicated a possible new variant, the case sample was resequenced, as
well as other available family members, and population controls.
These data were analyzed using the same method.
For any coding variant, we performed direct sequencing in 186
population-matched controls. Control populations were collected as
described above for the cases and consisted of individuals with no CL/
P or other recognized birth defect from adults at the same sites where
cases were collected. If the variant was found in one or more controls,
it was considered a polymorphism. To expand the number of controls
tested, we developed allele-speciﬁc assays for the LHX8 E221A, SATB2
T190A, SKI A388V, SPRY2 D20A, and TBX10 R354Q mutations. We
tested them in the CEPH Diversity Cell Line Panel [31], which is
comprised of 1,064 DNA samples from cultured lymphoblastoid cell
lines derived from individuals representing 51 different human
populations.
We also developed an assay for the MSX1 P147Q missense
mutation, recently reported in three Vietnamese cleft families [5].
Besides the 1,064 CEPH Diversity Cell Line Panel controls, we tested
theMSX1 P147Q assay in an additional 607 Filipino controls and in a
collection of 1,468 cleft cases from the Philippines as well.
For the nine genes with potentially etiologic missense mutations,
we identiﬁed orthologs through BLAST search of the non-redundant
database using Homo sapiens FOXE1, GLI2, LHX8, JAG2, MSX2, SATB2,
SKI, SPRY2, and TBX10, as reference sequences. We performed
protein sequence comparisons with the available species. We also
used the ESEﬁnder software available online to predict the presence
of exonic splicing enhancers [14], which appear to be prevalent, and
may be present in most, if not all exons [32,33]. We screened the 141
exonic splicing silencer decamers that were identiﬁed by Wang et al.
[34] to check if any of those could be affected by the missense
mutations we found. Finally, we used the PolyPhen software, also
available online, to predict the impact of the amino acid substitu-
tions identiﬁed on the structure and function of the human protein
[35–37].
Two single nucleotide polymorphisms in weak linkage disequili-
brium with each other were selected for each population to perform
linkage disequilibrium studies in the genes with missense mutations
in cases but not in controls. Four single nucleotide polymorphisms
were chosen for GLI2 based on the International HapMap Project’s
linkage disequilibrium pattern of the gene (data not shown).
Frequency of the alleles can be found in the supplemental material
(http://genetics.uiowa.edu/publications.html). TaqMan-based assays
[38] were performed on Applied Biosystems 7900 HT Sequence
Detection System (Applied Biosystems, Foster City, California, United
States). For one marker in SKI (rs2843159), we used a kinetic
polymerase chain reaction assay previously reported [39]. These
linkage disequilibrium studies were composed of 296 complete triads
(mother/father/affected child) from the Philippines and 205 from
Iowa. These samples were obtained as described above for cases and
controls investigated by sequencing. The Family Based Association
Test (FBAT) [40–42] program was used for this analysis. Signiﬁcance
ﬁgures were accounted for using Bonferroni correction taking into
account the number of tests carried out [43]. With the Bonferroni
correction, alpha is 0.0003 (0.05/192 comparisons) for the individual
marker analysis and 0.0001 (0.05/384 comparisons) for the haplotype
analysis. Linkage disequilibrium studies for FOXE1 were previously
reported in Marazita et al. [7].
A third clefting population sample set of 434 case/mother pairs
from South America was used to replicate any signiﬁcant association.
These population samples are derived from ECLAMC, which is a
hospital-based birth defects registry study that includes sites in
Argentina, Bolivia, Brazil, Chile, Ecuador, Paraguay, Uruguay, and
Venezuela. This study population has previously been described in
detail [44,45]. To analyze the ECLAMC samples, the likelihood ratio
test (LRT) of Weinberg [46] was applied under the assumption that
the distribution of paternal alleles is the same as maternal.
Supporting Information
Figure S1. Protein Comparisons of the Available Gene Orthologs for
the Mutations Found in the Present Study
Green bars indicate degree of conservation in each site. Amino acids
in red indicate the mutation sites. All mutation comparisons are
available as supplemental material at http://genetics.uiowa.edu/
publications.html.
Found at DOI: 10.1371/journal.pgen.0010064.sg001 (56 KB PDF).
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Table S2. Exonic Splicing Enhancer Prediction Analysis for the
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Missense Mutations Found in the Present Study. Nucleotides in red
indicate the mutation sites.
Found at DOI: 10.1371/journal.pgen.0010064.st002 (61 KB PDF).
Table S3. Mutations Screened in the CEPH Diversity Cell Line Panel
Found at DOI: 10.1371/journal.pgen.0010064.st003 (48 KB PDF).
Table S4. Markers Selected for Linkage Disequilibrium Studies
Found at DOI: 10.1371/journal.pgen.0010064.st004 (49 KB PDF).
Table S5. Haplotype Frequencies
Found at DOI: 10.1371/journal.pgen.0010064.st005 (46 KB PDF).
Table S6. Linkage Disequilibrium Studies of Candidate Genes for
Clefting
Found at DOI: 10.1371/journal.pgen.0010064.st006 (50 KB PDF).
Table S7. Haplotype Analysis
Found at DOI: 10.1371/journal.pgen.0010064.st007 (54 KB PDF).
Table S8. SKI LRT Results for the South American (ECLAMC)
Clefting Samples
Found at DOI: 10.1371/journal.pgen.0010064.st008 (40 KB PDF).
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